C-peptide
Showing 1 - 25 of >10,000
Transient; Hypoglycemia, Neonatal, Preterm, Glibenclamide Adverse Reaction Trial in Paris (Glibenclamide, Pharmacokinetics
Not yet recruiting
- Transient; Hypoglycemia, Neonatal
- +2 more
- Glibenclamide
- +5 more
-
Paris, FranceHopital Necker - Enfants malades
Jan 6, 2023
Diabetes, Type 1 Trial (Abrocitinib 200 MG Oral Tablet, Ritlecitinib, Placebo)
Not yet recruiting
- Diabetes Mellitus, Type 1
- Abrocitinib 200 MG Oral Tablet
- +2 more
- (no location specified)
Feb 21, 2023
Development ofNovel Method to Measure Insulin Sensitivity in
Completed
- Insulin Sensitivity
- 24h Continuous glucose monitoring and urinary C-peptide collection
-
Baton Rouge, LouisianaPennington Biomedical Research Center
Jun 12, 2022
Carotid Atherosclerosis Trial in Saint Louis (Cu[64]-25%-CANF-Comb PET-MR)
Completed
- Carotid Atherosclerosis
- Cu[64]-25%-CANF-Comb PET-MR
-
Saint Louis, MissouriWashington University in St.Louis
Oct 13, 2022
Development of Predictive Biomarkers
Completed
- Type1diabetes
- Mixed Meal Tolerance Test
-
Milwaukee, WisconsinMedical College of Wisconsin
Nov 28, 2021
Migraine, Episodic Migraine, Headache Trial in New York (Click Digital Therapeutic)
Recruiting
- Migraine
- +3 more
- Click Digital Therapeutic
-
New York, New YorkClick Therapeutics
Aug 15, 2023
Healthy Trial (Peptide complexed HA Age Defying Gel with Vitamin C & Niacinamide, Peptide complexed HA Age Defying Gel with
Not yet recruiting
- Healthy
- Peptide complexed HA Age Defying Gel with Vitamin C & Niacinamide
- +4 more
- (no location specified)
Dec 11, 2022
Polycystic Ovary Syndrome, c Type Natriuretic Peptide, Menstrual Irregularity Trial in Nicosia (C type natriuretic peptide)
Completed
- Polycystic Ovary Syndrome
- +3 more
- C type natriuretic peptide
-
Nicosia, CyprusNear East University Faculty of Medicine
Oct 7, 2021
CANF-Comb-II PET-MR in Atherosclerosis Multisite
Recruiting
- Carotid Atherosclerosis
- +2 more
-
Los Angeles, California
- +1 more
Apr 27, 2023
Diabetes Type One in Pregnancy and Continuos Glucose Monitoring
Recruiting
- Large-for-gestational-age Neonates
- +4 more
-
Zagreb, CroatiaUniversity hospital centre Zagreb
Aug 2, 2021
Hiv Trial in Philadelphia (Autologous CD4 T-Cells)
Completed
- Hiv
- Autologous CD4 T-Cells
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Nov 13, 2022
Post Concussive Symptoms Trial (Early intervention programme, Enhanced usual care)
Active, not recruiting
- Post Concussive Symptoms
- Early intervention programme
- Enhanced usual care
- (no location specified)
Apr 11, 2023
Alcohol Use Disorder Trial in Pittsburgh ([C-11], NOP-1A)
Completed
- Alcohol Use Disorder
- [C-11]
- NOP-1A
-
Pittsburgh, PennsylvaniaUniversity of PIttsburgh PET Facility
Jul 8, 2022
Diffuse Hemispheric Glioma, H3 G34-Mutant Trial in Los Angeles (biological, procedure, drug)
Not yet recruiting
- Diffuse Hemispheric Glioma, H3 G34-Mutant
- Dendritic Cell Tumor Peptide Vaccine
- +6 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Jul 13, 2022
HIV Trial in Rochester, Nashville, Seattle (HIV-1 C4-V3 Polyvalent Peptide Vaccine)
Completed
- HIV Infections
- HIV-1 C4-V3 Polyvalent Peptide Vaccine
-
Rochester, New York
- +2 more
Oct 27, 2021
Solid Tumor, Adult, EphA2 Overexpression, KRAS G12V Trial in Beijing (KRAS-EphA-2-CAR-DC, Abraxane, Cyclophosphamide)
Recruiting
- Solid Tumor, Adult
- +4 more
- KRAS-EphA-2-CAR-DC
- +3 more
-
Beijing, Beijing, ChinaBiotherapeutic Department of Chinsese PLA Gereral Hospital
Nov 29, 2022
Type 1 Diabetes Trial in Uppsala (Liraglutide, Placebo for liraglutide)
Completed
- Type 1 Diabetes
- Liraglutide
- Placebo for liraglutide
-
Uppsala, SwedenUppsala University Hospital
Nov 4, 2020
Type 1 Diabetes Trial in Duarte (Tolerogenic Dendritic Cell Vaccine)
Recruiting
- Type 1 Diabetes Mellitus
- Tolerogenic Dendritic Cell Vaccine
-
Duarte, CaliforniaCity of Hope Medical Center
Jul 26, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +20 more
- Neoantigen Peptide Vaccine
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 7, 2022
Diabetes, Type 2, Depressive Symptoms Trial in Jakarta Pusat (Cholecalciferol 4000 IU Oral Capsule, Liquid Filled, Placebo)
Recruiting
- Diabetes Mellitus, Type 2
- Depressive Symptoms
- Cholecalciferol 4000 IU Oral Capsule, Liquid Filled
- Placebo
-
Jakarta Pusat, DKI Jakarta, IndonesiaCipto Mangunkusumo National General Hospital
Jun 7, 2021
Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7 Trial in United States
Recruiting
- Breast Adenocarcinoma
- +7 more
- Multi-epitope HER2 Peptide Vaccine TPIV100
- +5 more
-
Scottsdale, Arizona
- +26 more
Aug 17, 2022
HIV Trial in Chicago, Durham, Galveston (Interleukin-12, HIV-1 C4-V3 Polyvalent Peptide Vaccine)
Completed
- HIV Infections
- Interleukin-12
- HIV-1 C4-V3 Polyvalent Peptide Vaccine
-
Chicago, Illinois
- +2 more
Oct 28, 2021
Vitamin D Deficiency Trial in Amman (VD3, Omega-3FA, VD3 and Omega-3FA)
Completed
- Vitamin D Deficiency
- VD3
- +3 more
-
Amman, JordanApplied Science University
Jul 12, 2020